搜索筛选:
搜索耗时0.4531秒,为你在为你在102,285,761篇论文里面共找到 11 篇相符的论文内容
发布年度:
[期刊论文] 作者：Qingyuan Zhang Guoqiang Zhang,
来源：现代交通：中英文版 年份：2013
...
[会议论文] 作者：Xingjian Niu,Qingyuan Zhang,
来源：2019中国肿瘤学大会 年份：2019
Objective Primary breast diffuse large B-cell lymphoma(PB-DLBCL),the most common histologic subtype of lymphoid malignancy in the breast,is a clinically and genetically heterogeneous disease that has...
Exploratory clinical study of chidamide, an oral subtype-selective histone deacetylase inhibitor, in
[期刊论文] 作者：Qingyuan Zhang,Tao Wang,Cuizhi,
来源：中国癌症研究:英文版 年份：2018
Objective:The recurrence or progression under endocrine therapy in hormone receptor-positive(HR+)advanced breast cancer(ABC) remained a critical clinical challe...
[期刊论文] 作者：MA Xiao,QI Qingyuan,ZHANG Huan,
来源：黑龙江科技学院学报 年份：2018
为探究吕家坨井田地质构造格局,根据钻孔勘探资料,采用分形理论和趋势面分析方法,研究了井田7...
Exploratory clinical study of chidamide, an oral subtype-selective histone deacetylase inhibitor, in
[期刊论文] 作者：Qingyuan Zhang,Tao Wang,Cuizhi Geng,Yue Zhang,Jinwen Zhang,Zhiqiang Ning,Zefei Jiang,
来源：中国癌症研究（英文版） 年份：2018
Objective:The recurrence or progression under endocrine therapy in hormone receptor-positive (HR+)advanced breast cancer (ABC) remained a critical clinical chal...
[期刊论文] 作者：DENG Xiangzheng,JIN Gui,HE Shujin,WANG Chengxin,LI Zhaohua,WANG Zhanqi,SONG Malin,YANG Qingyuan,ZHANG,
来源：Journal of Geographical Sciences 年份：2021
In this paper, we review the research progress in development geography since the 20th century, focusing on its connotation and theory, fields, methods, and development trends. Specifically, we system...
[期刊论文] 作者：Xiaonan Hong,Yuqin Song,Yuankai Shi,Qingyuan Zhang,Wei Guo,Gang Wu,Junmin Li,Jifeng Feng,Anastasiia Kinkolykh,
来源： 年份：2022
...
Phase 1 studies comparing safety, tolerability, pharmacokinetics and pharmacodynamics of HLX01(a rit
[期刊论文] 作者：Yuankai Shi,Qingyuan Zhang,Xiaohong Han,Yan Qin,Xiaoyan Ke,Hang Su,Li Liu,Jinxiang Fu,Jie Jin,Jifeng,
来源：中国癌症研究:英文版 年份：2021
Objective: This study aimed to compare the pharmacokinetic, pharmacodynamic and safety profiles of HLX01(a rituximab biosimilar) and reference rituximab sourced from China(Mab Thera?;rituximab-CN).Methods: Here we report the results of two ......
Phase 1 studies comparing safety,tolerability,pharmacokinetics and pharmacodynamics of HLX01(a ritux
[期刊论文] 作者：Yuankai Shi,Qingyuan Zhang,Xiaohong Han,Yan Qin,Xiaoyan Ke,Hang Su,Li Liu,Jinxiang Fu,Jie Jin,Jifeng,
来源：中国癌症研究（英文版） 年份：2004
Objective:This study aimed to compare the pharmacokinetic,pharmacodynamic and safety profiles of HLX01(a rituximab biosimilar)and reference rituximab sourced fr...
[会议论文] 作者：Ping Zhang Tang,Myung-Ju Ahn,Qingyuan Zhang,Anthony Chan,Sung-Bae Kim,Cheng-Hsu Wang,Xiaohui He,Wei Guo,
来源：2016第九届世界癌症大会 年份：2016
Background: Head and neck squamous cell carcinoma (HNSCC) patients who progress after first-line platinum-based chemotherapy (CT) for recurrent and/or metastatic (R/M) disease have few treatment optio...
[期刊论文] 作者：Yi Ba,Yuankai Shi,Wenqi Jiang,Jifeng Feng,Ying Cheng,Li Xiao,Qingyuan Zhang,Wensheng Qiu,Binghe Xu,Ruihua,
来源：癌症生物学与医学（英文版） 年份：2020
Chemotherapy-induced neutropenia (CIN) is a potentially fatal and common complication in myelosuppressive chemotherapy. The timing and grade of CIN may play pro...
相关搜索：
